Get started
Live feed
·
PRReleasevia Quantisnow
Eiger BioPharmaceuticals Inc. logo

Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO

ByQuantisnow·Wall Street's wire, on your screen.
EIGREiger BioPharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EIGR (Eiger BioPharmaceuticals Inc.) and more on Quantisnow.